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Draft genome sequences for Schistosoma
japonicum and Schistosoma mansoni are now
available. The schistosome genome en-
codes approximately 13,000 protein encod-
ing genes for which the function of only a
small minority is understood. The new
genes represent potential intervention tar-
gets. Molecular tools are needed to deter-
mine the importance of these new genes.
There is a role for transgenesis in functional
genomics of the new schistosome gene
sequences, both in gain- and loss-of-func-
tion approaches such as insertional muta-
genesis screens and vector-based RNA
interference. This laboratory symposium
focuses on the development of approaches,
systems,and tools to address the problem of
establishing transgenic schistosomes which,
in turn, can be applied to fundamental
questions of schistosome physiology, the
host–parasite relationship, and to develop-
ing new interventions.
The Problem
Control of schistosomiasis largely
relies on chemotherapy, but people rap-
idly become re-infected and the wide-
spread use of praziquantel has led to
concerns about development of drug
resistance. Advances in molecular genet-
ics, biochemistry, and vaccinology hold
promise to control the spread of schisto-
somiasis and to combat the morbidity and
mortality associated with this neglected
tropical disease. Draft genome sequences
for Schistosoma japonicum and Schistosoma
mansoni are available [1,2]. Molecular
tools are needed to determine the impor-
tance of newly identified genes. Problem-
atically, few functional genomics tools are
available for schistosomes. The potential
value of transgenesis approaches for
schistosomes is obvious given the progress
made in model species and cell lines and
indeed more tractable pathogenic species
(e.g., [3–5]). There is a valuable role for
transgenesis in functional genomics for
investigation of schistosome genes. Devis-
ing tools to create transgenic schistosomes
and deploying transgenic schistosomes in
functional genomics analysis will advance
knowledge of schistosomes and schistoso-
miasis.
Tutorial
Why Pursue Transgenesis for
Schistosomes?
Transgenesis, including somatic and
germ line approaches, is a desirable
goal. It is a well-established approach for
functional genomics in model species
including Caenorhabditis elegans and Drosoph-
ila melanogaster (e.g., [6]). It should be able
to facilitate gain-of-function and/or loss-
of-function phenotypic and molecular
analysis in schistosome parasites. Trans-
genesis approaches can facilitate vector-
based RNA interference, and would be a
potential forward genetic technology for
insertional mutagenesis screens, which are
feasible now that draft schistosome ge-
nome sequences are available. In addition,
transgenes are potential tools for develop-
ment of genetic therapy and/or vaccines.
Approaches being developed for schisto-
some transgenesis include deployment of
integration-competent vectors such as
transposons and retrovirus. Integration-
competent vectors are expected to lead to
insertion of transgenes into schistosome
chromosomes.
Which Vectors Can Be Used to
Produce Transgenic Schistosomes?
Both integration-competent and non-
integrating plasmids have been used to
introduce transgenes into schistosomes [7–
9]. Although both approaches have utility,
there are compelling reasons to focus on
integration-competent vectors, primarily
because integrated transgenes can be
propagated equally and reliably to the
progeny of the transduced cell, includ-
ing germ line cells. Integration-competent
vectors include DNA transposons such as
mariner, Sleeping Beauty, and piggyBac, and
simple and complex retroviruses including
murine leukemia viruses and lentiviruses
such as HIV-1. Indeed, colleagues in our
lab have demonstrated the proof of this
principle by showing that the transposon
piggyBac is transpositionally active in S.
mansoni [8], and the vesicular stomatitis
virus glycoprotein (VSVG)-pseudotyped mu-
rine leukemia retrovirus (MLV) can trans-
duce S. mansoni and S. japonicum,l e a d i n gt o
active proviral reporter transgenes integrated
in the schistosome chromosomes [9–11].
Other approaches including deployment of
bacteriophage integrases and fungal recom-
binases, which have found service in genome
manipulation of, for example, Plasmodium
falciparum, may also be of use [12,13], but
have not yet been reported with schistosomes.
Which Developmental Stages Might
Be Targeted?
Theoretically, the schistosome genome is
targetable at any stage of parasite develop-
ment given that for S. mansoni, for instance,
the entire developmental cycle can be
maintained in the laboratory in Biomphalaria
species snails and the laboratory mouse
(Figure 1). Some stages can be cultured ex
vivo or in vitro, and returned to the snails or
mice to continue development (see [14]).
Other stages have potential advantages as
targets for transgenes given their accessibil-
ity, tolerance to manipulation, size, and/or
ratio of germ to soma (e.g., [10,15]). Also,
schistosome stages are differentially accessi-
ble to delivery of transgenes, using ap-
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bardment, square wave electroporation,
cationic polymer-based gene delivery, and
infection of schistosomes with pseudotyped
retrovirus [7,16,17]. Other approaches,
including microinjection, should be of value,
as indicated by progress with introduction of
transgenes in parasitic nematodes [18]. The
schistosome egg and the miracidium that
hatches from the mature egg have desirable
attributes for consideration in relation to
transgenesis. These include the presence of
the single cell zygote within the eggshell
upon its release from the female blood fluke,
high ratio of germ to somatic cells, ease of
maintenance in vitro, accessibility of embry-
onic cells within the egg to transgenes of
pseudotyped retrovirus virions,and ability of
the miracidium, which is readily released
from the mature egg by transfer of the
cultured egg into sterile water to naturally
infect the intermediate host snail [19,20].
The attributes also include availability of
eggs from livers of experimentally infected
rodents [7,14] and ability of the female to
deposit viable eggs in vitro [21] (see below).
Moreover, from a clinical perspective, the
egg represents the major source of patho-
genesis. Figure 1 outlines strategies that can
explored to direct transgenes to the germ
line of S. mansoni involving the asexual and
sexual reproduction processes of the devel-
opmental cycle of the parasite.
Eggs and miracidia. In the first
report of vertical or germ line transgenesis
in schistosomes, Grevelding and colleagues
[7] transfected miracidia with plasmid
DNA encoding green fluorescent protein
(GFP) driven by the schistosome actin gene
promoter, and reported that the GFP
transgene was transmitted to the F1 ge-
neration of miracidia, via passage through
snails and mice. Transmission to the F2 and
F3 generations was not apparent, though,
likely because the transgene transmission
as episomal and the extra-chromosomal
transgene was diluted and/or lost in
subsequent development and generations.
Non-integrated, extra-chromosomal arrays
of plasmid transgenes are the normal
occurrence in transgenic C. elegans where
transgene DNA assembles through non-
homologousrecombination into multi-copy
concatemers or extra chromosomal arrays.
These are inherited in non-Mendelian
fashion. Nonetheless, integration into the
C. elegans genome will improve transmission
to the progeny (see [22]). Recently,
we demonstrated the feasibility of
manipulating eggs of S. mansoni. Eggs
from mouse livers were soaked and/or
electroporated with different reporter
transgenes including MLV virions. Eggs
were transduced with virions after which
retroviral transgenes were detected and
quantified in the genome of miracidia by
real-time PCR [20].
In vitro laid eggs (IVLE). We have
begun to focus on eggs laid in vitro by
females aiming to target transgenes to the
zygote or to the early blastula where the
total number of cells would be less than in
Figure 1. Schematic representation of general strategies that can be explored to introduce transgenes into the germ line involving
the asexual (A) and sexual (B) reproduction processes of the developmental cycle of S. mansoni. In brief, eggs/miracidia, sporocysts, and/
or schistosomula might be transduced by VSVG-pseudotyped Moloney murine leukemia retrovirus. Subsequently, snails can be infected with
miracidia by the natural percutaneous route or with sporocysts by microinjection and mice infected by the parenteral route with transformed
schistosomules or by the natural percutaneous route by cercariae. Progeny cercariae from snails and eggs from mice can be analyzed for transgenes
and/or reporter transgene activities. The green colored cells in illustrations of larvae represent the potential presence of transgenes in germ line and/
or somatic cells.
doi:10.1371/journal.pntd.0001230.g001
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somatic cell ratio would be higher, which
would enhance the likelihood of transfecting
germ cell(s), a prerequisite for perpetuating
an entirely transgenic schistosome or a
mosaic form comprising transgenic and
non-transgenic tissues. One approach to
this goal involves culturing schistosomes
recovered from mice and collection of eggs
laid in vitro by these worms within 48 hours.
(Eggs laid after the females have been
in culture for .48 hours do not develop
correctly [21].) With these in vitro laid
eggs (we abbreviate as IVLE), we follow
the protocol of Mann et al. [14], with mo-
difications. We transfer adults into schi-
stosomule medium and maintain them at
37uC immediately after perfusion from mice,
and transfer the worms as soon as practicable
into 74-mm diameter mesh netwell, 6-well
plates (Fisher Bioscience, catalog no. 0720-
0213). The worms are maintained in schi-
stosomule medium in netwell plates for
48 hours after perfusion. IVLE and, occa-
sionally, adult females fall through the mesh
and collect on the bottom of the culture plate
(Figure 2A). At 48 hoursafter perfusion of the
worms from mice, we collect IVLE, and
concentrate by filtering media containing
IVLE through 0.8-mmm e s ht r a n s w e l l( B D
Biosciences, catalog no. 353097) (Figure 2B,
2C). Thereafter, IVLE are maintained in
schistosomule medium where they develop
and mature within 7 days (Figure 2D–2J). At
that point, we transferred IVLE to sterile
water, illuminated the culture with a bright
lamp, and observed that many eggs (30% to
40%) hatch within 120 minutes. We
observed that miracidia hatched from IVLE
infected Biomphalaria glabrata snails from
which, in turn, cercariae were released after
6 weeks (Figure 2K–2M). IVLE represents
a tractable, developmental stage at which
to target transgenes, especially since in
developmental stages 0 and 1 (staging
system of Jurberg et al. [19]), no cleavage
of the zygote cell has yet taken place. In
future studies, we plan to expose IVLE to
pseudotyped MLV virions at the time eggs
are released from the female schistosome,
aiming to introduce transgenes into the
schistosome germ line. (The studies with
schistosome-infected laboratory mice were
undertaken with the approval of the IAC-
U Co fT h eG e o r g eW a s h i n g t o nU n i v e r s i t y ,
Washington, D.C.).
How Can We Increase the Likelihood
of Chromosomal Integration?
For transposons, in particular for binary
versions of broad host range vectors such
as piggyBac and Sleeping Beauty (e.g., [4,8]),
increased efficiency of integration can be
accomplished using mRNA encoding
the transposase rather than using helper
plasmid, and further, optimal ration of
transposon and transposase can be titrat-
ed. Also, transposase enzyme can be
employed instead of mRNA of the gene
Figure 2. Representative pictures of the in vitro laid eggs (IVLE) collection, concentration, and in vitro development. (A) Female of
S. mansoni releasing eggs one day after perfusion. The mesh of the netwell is evident. (B) Female surrounded by IVLE in the bottom of the well. (C)
IVLE during the concentration process 48 hours after perfusion. (D–J) Representative images of an individual egg laid in vitro through the
developmental process from day 1 (D), 2 (E), 3 (F), 4 (G), 5 (H), and 6 (I) to day 7 (J) after perfusion. (K) IVLE during the hatching process; arrows
indicate empty eggshells. (L) Diagram of snail infection. (M) Cercariae released from snails infected with miracidia from IVLE, at 42 days after snail
infection. Scale bars: (A–C,K,M), 200 mm; (D–J), 20 mm.
doi:10.1371/journal.pntd.0001230.g002
www.plosntds.org 3 August 2011 | Volume 5 | Issue 8 | e1230[3]. For retroviruses, in particular MLV,
with which we have some experience,
increasing the titer of active virions is a
sound way to improve prospects for
productive transduction of target germ
line cells. Given the progress with trans-
genesis of schistosomes with pseudotyped
MLV [9–11,20,23,24], comments on viri-
on production are included below.
Can virion production be optimiz-
ed? There are several factors to consider
for an optimal virus production, including
producer (host) cell strain and culture
conditions, cell density and vitality by the
time of the DNA transfection, amount
and quality of plasmid DNA used
for transfection, and recovery of viral
particles. Factors that reduce the retrovirus
half-life also should be considered, i.e.,
storage of virions, freeze-and-thaw cycles,
temperature, pH, and presence of serum
[25]. The higher the viral titer, the better the
prospects are for chromosomal insertion of
the proviral transgene [26]. Although
protocols to produce retrovirus in vitro
optimize to improve titers, contamination
of virions with defective particles is a
frequent problem. Defective virions include
particles without envelope, without RNA, or
with RNA but non-infectious [27]. Using at
least two approaches to estimate viral titer is
recommended [25,27]. One approach
should estimate the titer of infectious
particles, i.e., a functional, biological assay
where a cell line is infected with serial
dilution of the virions and colonies of cells
are selected by maintenance in antibiotic for
which resistance is conferred by the
retrovirus. Second, a quantitative approach
to estimate the copy number of particles by
qPCR should also be performed in parallel.
With findings from the parallel assay, total
Figure 3. Correlating RNA titer with infectivity. Schematic diagram of two MLV and HIV representative constructs and corresponding
micrographs of the particles (from Higashikawa et al. [25], with permission). To determine infectivity titers, NIH 3T3 or HT1080 cells were infected with
qRT-PCR-titrated MLV retrovirus or qRT-PCR-titrated HIV, carrying neomycin (Neo) or blasticidin (Blast) resistance genes, respectively. Cells were
selected in G418 or blasticidin for 10 days and resistant colonies were stained and counted.
doi:10.1371/journal.pntd.0001230.g003
www.plosntds.org 4 August 2011 | Volume 5 | Issue 8 | e1230Figure 4. Approaches to identify, clone, and quantify integrated sequences into the schistosome genome. (A) Integration of retroviral
provirus into the S. mansoni genome indicated by Southern hybridization analyses of genomic DNA from retrovirus-transduced schistosomes. Top
Panel: Schematic representation of retroviral construct pLNHX-SmACT-Luc, showing the position of Nco I cleavage sites and also the location of the
Kpn I fragment employed as the hybridization probe. The retrovirus cassette included the firefly luciferase reporter gene (yellow) driven by the
S. mansoni actin 1.1 gene promoter (blue), and flanked by the 59- and 39-long terminal inverted repeats of the murine leukemia virus (grey). The
cassette also included the gene endowing neomycin resistance (pink) and the psi motif (light yellow; involved in packaging the viral DNA). Bottom
Panel: Southern hybridization analysis of genomic DNA from schistosomules transduced by VSVG-pseudotyped retrovirus. Left side: ethidium-stained
gel of genomic DNAs of S. mansoni: lane 1, Nco I-digested gDNA from control, non-virus transduced cercariae; lane 2, Nco I-digested gDNA from
schistosomules exposed to VSVG-pseudotyped pLNHX-SmACT-Luc virions; lane 3, Nco I-digested plasmid pLNHX-SmACT-Luc. Molecular size
standards in kilobases (kb) shown at margin. Right side: autoradiograph of Southern hybridization signals from the Nco I-digested gDNAs and
plasmid DNA from the left-side panel to the radiolabeled transgene probe (5.3 kb Kpn I fragment of pLNHX-SmACT-Luc, top panel). (Modified from [9]
with permission.) (B) Top Panel: Schematic representation of the RAP technique, designed to recover integration junctions between integrated
retroviral provirus and endogenous mobile genetic elements resident within the S. mansoni genome. (1) Schematic representation of the integration
of the MLV retrovirus into schistosome chromosomes after transduction of cultured schistosomes by VSVG-pseudotyped MLV virions. Endogenous
retrotransposons within the schistosome chromosomes are shown; numerous copies of SR1, Boudicca, and the fugitive have been described
interspersed throughout the S. mansoni genome. (2) Schematic depiction of the RAP technique used to investigate transgene integrations. The
position of the primers used in the PCRs and the probe used in Southern hybridizations is indicated. Bottom Panel: Left side. Ethidium-stained gels
revealing RAP products amplified from gDNA extracted from schistosomula transduced with VSVG-pseudotyped pLNHX-SmACT-Luc virions; the PCR
products were amplified using primers specific for the endogenous schistosome retrotransposons and the luciferase transgene. Right side: Southern
hybridization of labeled retroviral transgene gene probe to the RAP products shown in top panel. Lane 1, RAP products amplified with luciferase left
and Boudicca forward-directed primers; lane 2, RAP products from luciferase left- and fugitive forward-directed specific primers; lane 3, RAP products
from luciferase left- and fugitive reverse-directed specific primers; lane 4, RAP products from luciferase left and SR1 forward-specific primers; lane 5,
RAP products from luciferase left- and SR1 reverse-specific primers; lane 6, RAP products from luciferase left- and SR2 forward-specific primers; lane 7,
RAP products from luciferase left- and SR2 reverse-specific primers; lane 8, RAP products from luciferase left- and SMa forward-specific primers. Values
at left are molecular size standards (kb). (Modified from Kines et al. [9], with permission) (C) Left Panel: Illustration of the quantitative retrotransposon
anchored PCR (qRAP). Schematic representation of the integration of the MLV retrovirus into schistosome chromosomes after transduction of
cultured schistosomes by VSVG-pseudotyped MLV virions. First PCR: 20 cycles of end-point PCR preamplification with primers that target
endogenous mobile genetic elements and luciferase transgene sequences. Heterogeneous amplicons of variable length are expected. Second PCR:
quantitative PCR to estimate the copy number of luciferase-specific sequences within the transduced schistosome genome. Quantification was
undertaken using copy number standards, i.e., 10-fold serial dilutions of the luciferase encoding plasmid pGL3, after which copy number of luciferase
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infectious particles can be established
[25,27]. We use both approaches to
estimate the viral titer and the ratio
between copy number of particles and
infectious units [24]. Figure 3 presents
representative findings from our labo-
ratory, for both MLV and HIV
pseudotyped virions; in general, titers
estimated by qPCR were two to three
orders of magnitude greater than those
estimated in biological assays. This is not
only because qPCR is more sensitive, but
also because qPCR detects non infec-
tive particles. Accordingly, the lower the
titration ratio, the more efficient is the virus
production in terms of viable infectious
particles.
How Can We Analyze Integration of
Transgenes into the Genome?
Integration is a pivotal step in estab-
lishing transgenic schistosomes. To con-
firm that vectors can integrate into
schistosome DNA, methods to deter-
mine and extract integration junctions
have to be employed. Integration junc-
tions cannot be obtained simply by
regular PCR procedures because the
genomic flanking sequences are un-
known. Southern hybridization employ-
ing informative restriction enzymes and
probes retain a key position in these
studies. For example, Figure 4A presents
a Southern hybridization analysis to
confirm the presence of proviral trans-
genes in the genome of schistosomules
exposed to pseudotyped MLV virions.
However, the definitive proof of integra-
tion of the transgenes into the schisto-
some chromosome requires the use of
P C R - b a s e da p p r o a c h e sd i r e c t e da tc l o n -
ing and sequencing the integration
junction (Figure 4B). Given that draft
genomes of S. mansoni and S. japonicum
are available, BLAST analysis of cloned
sequences flanking the transgenes (e.g.,
MLV retrovirus) can readily verify that
the transgenes have integrated into a
schistosome chromosome. A number of
PCR-based methods can be employed to
recover integration events and unknown
host genome sequences flanking the
t r a n s g e n e .T h e s ei n c l u d ei n v e r s eP C R ,
linker ligation PCR and thermal asym-
metric interlaced (TAIL)-PCR, and Alu-
PCR [28,29]. We developed an Alu-
PCR-like approach termed retrotranspo-
son anchored PCR (RAP) [8,9], which
relies on anchoring primers to multi-
copy endogenous mobile genetic ele-
ments interspersed in the schistosome
genome to locate integration junctions of
transgenes in the genome of S. mansoni
( F i g u r e4 B ) .F u r t h e r m o r e ,w eh a v e
adapted RAP for quantitative PCR in
order to determine comparatively the
number of MLV transgenes within the
genome of transduced populations of
schistosomes (Figure 4C) [24]. In addi-
tion, very high-throughput sequencing
using Illumina technology could be
utilized, as has been demonstrated for
transposon-based insertional mutagene-
sis of Salmonella Typhi [3]. This latter
approach could determine the exact
location of transgenes within the schis-
tosome genome.
Outlook
As noted, transgenic schistosomes have
been created (e.g., [7–9,23]). However,
improvements are needed—and certain to
take place—in order to establish transgen-
ic schistosomes and protocols. A crucial
impediment to date has been the difficulty
of delivering transgenes to chromosomes
of the germ line. Targeting integration-
competent vectors to IVLE may surmount
this limitation. Moreover, there are other
points in the developmental cycle where
the germ line might be accessed, including
the daughter sporocysts where the germ
cells are comparatively large (Coustau and
Yoshino [30] and references therein). We
can look forward to advances in technol-
ogies that will drive functional genomics
forward quickly, including expansion of in
vivo RNAi, high-throughput insertional
mutagenesis and, hopefully, gains-of-func-
tion approaches involving drug selection of
transgenic schistosomes. Advances in S.
mansoni can be expected to be adapted to
the other schistosomes, to the food-borne
flukes such as Fasciola and Opisthorchis
species, and to neglected helminth para-
sites at large.
Supporting Information
Alternative Language Abstract
S1 Translation of Abstract into Thai by
Sutas Suttiprapa.
(PDF)
Alternative Language Abstract
S2 Translation of Abstract into Spanish
by Gabriel Rinaldi.
(PDF)
transgene in schistosome genomic DNAs was calculated by interpolation from a standard curve. Right Panel: Amplification plots observed in MLV-
transduced worms in preamplified template using SR2 primer mix (red arrow), in preamplified template using only the luciferase transgene–specific
primer as control of ‘‘one-way amplification’’ (blue arrow), and in non-preamplified template (black arrow). Arrows indicate the threshold cycle. RT:
endogenous retrotransposon. (Modified from Rinaldi et al. [24], with permission.)
doi:10.1371/journal.pntd.0001230.g004
Key Learning Points
N Draft genome sequences for S. mansoni and S. japonicum are now available.
Accordingly, there is a pressing need now to develop functional genomics tools
for schistosomes to determine the importance of these new genes.
N Functional genomics approaches hold promise to determine the nature and
importance of genes of the human schistosomes.
N Retroviral and transposon-mediated gene manipulation, using integration-
competent, vector-based technologies, have been shown to be feasible for
schistosomes.
N The retrovirus murine leukemia virus, which is widely used in stem cell and
gene therapy research, and the piggyBac transposon, originally isolated from
the genome of a moth, have now been shown to be active in schistosomes, to
integrate into schistosome chromosomes, and to provide gains-of-function for
the reporter genes firefly luciferase, GFP, and neoR.
N Both MLV and piggyBac both have potential in high-throughput insertional
mutagenesis studies, feasible now that draft genome sequences are available.
N Vector-based RNAi—retroviral vector-mediated RNA interference demonstrated
in schistosomes—targeting a hemoglobin-digesting protease provides proof-
of-principle that vector-based RNAi is feasible to target any of the ,13,000
protein encoding genes of the schistosome.
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